View More Recent Stories

Nov 12, 2024 08:08AM Replimune Group, Inc. (REPL) Tops Q2 EPS by 14c
Sep 16, 2024 07:12AM H.C. Wainwright Reiterates Buy Rating on Replimune Group (REPL)
Sep 10, 2024 08:17AM BMO Capital Reiterates Outperform Rating on Replimune Group (REPL)
Sep 10, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Replimune Group (REPL)
Sep 9, 2024 09:37AM Roth/MKM Reiterates Buy Rating on Replimune Group (REPL)
Sep 9, 2024 08:01AM Replimune (REPL) Reports Positive Pre-BLA Meeting with FDA and Confirms BLA Submission On Track for 2H 2024
Sep 5, 2024 08:04AM Replimune (REPL): Stockholders Vote to Elect Madhavan Balachandran to Board of Directors
Aug 27, 2024 04:04PM Roth/MKM Starts Replimune Group (REPL) at Buy
Aug 13, 2024 08:01AM Replimune (REPL) Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma
Aug 8, 2024 09:27AM Replimune Group, Inc. (REPL) Tops Q1 EPS by 8c
Jun 13, 2024 08:33AM Replimune (REPL) Announces $100 Million Private Placement Financing
View More Recent Stories